Citation Information :
Maqbool M, Shah ZA, Wani FA, Wahid A, Parveen S, Nazir A. Prevalence of occult adrenal insufficiency and the prognostic value of a short corticotropin stimulation test in patients with septic shock. Indian J Crit Care Med 2009; 13 (2):85-91.
Background: Corticosteroid insufficiency in acute illness can be difficult to discern clinically. Occult adrenal insufficiency (i.e., Δmax ≤9 μg/dL) after corticotropin may be associated with a high mortality rate. Objective: To assess the prevalence of occult adrenal insufficiency and the prognostic value of short corticotropin stimulation test in patients with septic shock. Materials and Methods: A total of 30 consecutive patients admitted in the adult intensive care unit of the Sheri Kashmir Institute of Medical Sciences who met the clinical criteria for septic shock were prospectively enrolled in the study. A low dose (1 μg) short corticotropin stimulation test was performed; blood samples were taken before the injection (T0) and 30 (T30) and 60 (T60) minutes afterward. Results: The prevalence of occult adrenal insufficiency was 57%. The 28-day mortality rate was 60% and the median time to death was 12 days. The following seven variables remained independently associated with death: organ system failure scores, simplified acute physiology score II score, mean arterial pressure, low platelet count, PaO 2: FIO 2, random baseline cortisol (T0) > 34 μg/dL, and maximum variation after test (Δmax) of ≤9 μg/dL. Three different mortality patterns were observed: (I) low (T0 ≤34 μg/dL and Δmax > 9 μg/dL; a 28-day mortality rate of 33%),(II) intermediate (T0 > 34 μg/dL and Δmax >9 μg/dL or T0 ≤34 μg/dL and Δmax ≤9 μg/dL; a 28-day mortality rate of 71%), and (III) high (T0 > 34 μg/dL and Δmax ≤9 μg/dL; a 28-day mortality rate of 82%). Conclusion: A short corticotropin test using low-dose corticotropin (1 μg) has a good prognostic value. High basal cortisol and a low increase in cortisol on corticotropin stimulation test are predictors of a poor outcome in patients with septic shock.
Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. J Clin Endo Metab 1998;83:1558-62.
Low dose ACTH test to assess the function of Hypothalamic-pitutary adrenal axis. Clin Endocr 1996;44:151-6.
comparioson of low dose short synecthane test (1mcg), the conventional dose short synecthane test (250 mcg) and insulin tolerance test for assessment of the hypothalamo-pitutary-adrenal axis in patients with pituitary disease. J Clin Endo Metab 1999;84:838-43.
Diagnosis of Adrenal Insufficiency in Severe Sepsis and Septic Shock. Am J Respir Crit Care Med 2006;174:1319-26.
Subclinical hypocortisolemia in patients with sepsis in a medical intensive care unit in India (The SHIPS Study). Indian J Crit Care Med 2004;8:162-7.
Gram negative bacteremia. Am J Med 1980;68:344-55.
Sepsis syndrome. Crit Care Med 1989;17:389-93.
Impact of encephalopathy on mortality in the sepsis syndrome. Crit Care Med 1990;18:801-6.
Prognostic values of tumor necrosis factor/cachectin, interleukin 1, interferon α, interferon γ in the serum of patients with septic shock. J Infect Dis 1990;161:982-7.
For the Methylprednisolone Severe Sepsis Study Group. Hypothermia in the sepsis syndrome and clinical outcome. Crit Care Med 1992;20:1395-401.
The clinical evaluation of new drugs for sepsis. JAMA 1993;270:1233-41.
A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000;283:1038-45.
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-71.
Baseline cortisol levels, cortisol response to corticotropin, and prognosis in late septic shock. Shock 2003; 31:1668-75.
Return of Corticosteroids for Septic Shock- new dose, new insights. Indian J Crit Care Med 2004;8:145-7.